2025 Exclusive Resources

Uncertainty is the only certainty in clinical trial supply chains. From shifting regulations to supply shortages and cybersecurity threats, one unexpected disruption can derail an entire trial. As we enter 2026, the stakes are higher than ever, and the key to success remains a proactive, strategic approach to risk management.

The Top 8 Risk Management Strategies is an essential, action-driven checklist designed to help clinical trial supply professionals identify, assess, and mitigate risks across the entire supply chain.

Download this piece to how to:

• Constantly Evaluate & Document Risks: Implement continuous monitoring and keep detailed records of potential vulnerabilities.
• Stay Informed on Geopolitical Events: Track shifts in regulations, trade policies, and supply chain logistics to anticipate disruptions.
• Monitor & Adapt to Regulatory Changes: Keep up with evolving guidelines and quickly adjust processes to maintain global compliance. 

Risk management isn’t just about crisis response, it’s about proactive prevention and this infographic will help you stay compliant with global regulations, minimise supply chain disruptions, rnsure patient access to critical trial materials, and enhance resilience in an unpredictable global industry.

Sustainability is no longer a choice, it’s a necessity in clinical trial supply chains. With increasing regulations, growing environmental responsibilities, and the push for more efficient, patient-centric operations, it’s time to take action. The Sustainability Improvement To-Do List is your clear, step-by-step guide to integrating sustainability into every stage of your supply chain, with a regional breakdown of sustainability initiatives across the EU, UK, and US.

Download to learn more about:

• Carbon Footprint Assessment: Measure emissions across production, transportation, and energy use to pinpoint areas for improvement.
• Carbon Offsetting Strategies: Balance unavoidable emissions through renewable energy investments and reforestation initiatives.
• Energy Efficiency Upgrades: Optimise machinery, reduce waste, and implement energy-saving technologies.
• Sustainable Transport Solutions: Lower emissions with low-emission vehicles, optimised delivery routes, and shipment consolidation.

The clinical trial supply landscape is more complex than ever, with regulatory changes, supply chain risks, and sustainability pressures which demand smarter, faster, and more efficient solutions. The key? Leveraging technology

The Top 10 Technologies Checklist is your ultimate guide to integrating cutting-edge digital tools for a seamless, risk-proof clinical trial supply chain.

This must-see infographic gives you everything you need to:

• Leverage AI, blockchain, IRT, and predictive analytics to automate and streamline supply chain processes.
• Enhance compliance & reduce risk by integrating the latest regulatory tech solutions.
• Optimise inventory management & tracking with real-time digital monitoring.
• Improve patient-centric logistics by ensuring timely and efficient trial material delivery.
• Boost sustainability by adopting smart, eco-friendly supply chain strategies.

In an era where clinical trials are becoming increasingly complex and global, developing a robust supply strategy is more critical than ever. This strategic framework is designed to help you navigate the complex landscape of clinical trial supply, offering a step-by-step approach to crafting a resilient and adaptable strategy.

As 2026 approaches, the clinical trials landscape is evolving rapidly—driven by innovative technologies, shifting patient needs, and a strong push for global inclusion. In this exclusive interview, Steve Jacobs, President of Global BioPharm Solutions, LLC, explains how clinical trial supply chains are being reshaped by new challenges and opportunities. From the rise of AI and automation to the shift towards decentralised, patient-centric trials, Steve offers valuable insights on how the industry can not only adapt but thrive.

Discover how embracing cutting-edge technology, reinforcing data integrity, and championing sustainability will future-proof clinical operations in a complex, diverse world.

Download the interview to learn more about:

• AI & Automation: Revolutionising trials by speeding up development, boosting efficiency, and enhancing data quality.
• Decentralisation & Patient-Centric Models: Elevating trial operations through improved enrolment and retention.
• Sustainability & Global Inclusion: Integrating greener practices while ensuring accessibility for diverse populations.

The clinical trial supply chain is undergoing a radical transformation. With the complexity of multi-indication treatments and rare disease trials driving new challenges, innovative technologies and strategies are now essential. As we head into 2026, these pressures are intensifying, making advanced solutions more critical than ever. In this interview, Steve Jacobs, President of Global BioPharm Solutions, LLC, explains how advanced tools and patient-centric approaches are reshaping every link in the supply chain.

Download this interview to learn more about:

• Transforming Clinical Supply Chains: AI and automation streamline data collection, enhance forecasting accuracy, and reduce manual inefficiencies to ensure timely supplies and improved operational performance.
• Decentralised Trials & Direct-to-Patient Models: Direct-to-patient approaches address recruitment challenges and complex multi-indication studies, elevating enrolment, retention, and overall supply chain effectiveness.
• Integrated Systems & Sustainability: Scalable, eco-friendly systems overcome packaging, regulatory, and drug return challenges while ensuring global access and robust data integrity.

Navigating the evolving landscape of clinical trial supply chain regulations is a continuous challenge for pharmaceutical companies, CROs, and solution providers. With shifting compliance requirements across the EU, UK, and US, staying ahead of regulatory updates is essential for seamless trial execution and patient safety - especially as we enter 2026, a year poised for further regulatory transformation.

This Fact Sheet breaks down the complexities of global clinical trial supply regulations, providing actionable insights to help CTS professionals mitigate risks, ensure compliance, and build resilient, patient-centric supply chains and includes expert insights from Kamal Amin, Head of Supply Management, Galderma and Steven Jacobs, President, Global BioPharm Solutions, LLC.

Download to learn more about:

• Regulatory Updates & Compliance: Understanding the latest changes in GDP, GMP, EU CTR, ICH E6 (R3), MDR, post-Brexit UK regulations, and FDA guidelines.
• Risk Mitigation Strategies: Identifying potential regulatory risks and implementing proactive compliance measures.
• Supply Chain Resilience: Developing strategies to enhance flexibility and stability in an evolving regulatory environment.
• Sustainability in Clinical Supply: Exploring global initiatives to integrate sustainability into supply chain operations.
• Patient-Centric Supply Chains: Ensuring timely and compliant delivery of trial materials to improve patient outcomes.